Kirk is a postdoctoral research associate in the Cardio-Respiratory Interface Section of the National Heart and Lung Institute. Kirk completed a BSc in Biological Sciences at the University of Reading and secured MRC funding for his PhD studies at the University of Leicester. Upon completion of his PhD in 2016 he took up a postdoctoral researcher position at Anglia Ruskin University on a British Heart Foundation funded project. Kirk joined Dr Michael Emerson’s Platelet Biology Group in January 2017 and is investigating the impact of antiretroviral therapies on platelet function.
Taylor KA, Mahaut-Smith MP, 2019, A major interspecies difference in the ionic selectivity of megakaryocyte Ca2+-activated channels sensitive to the TMEM16F inhibitor CaCCinh-A01, Platelets, ISSN:0953-7104
et al., 2019, Pharmacological impact of antiretroviral therapy on platelet function to investigate HIV-associated cardiovascular risk, British Journal of Pharmacology, Vol:176, ISSN:0007-1188, Pages:879-889
et al., 2019, Agonist-evoked increases in intra-platelet zinc couple to functional responses, Thrombosis and Haemostasis, Vol:119, ISSN:0340-6245, Pages:128-139
et al., 2019, Investigation of the impact of antiretroviral therapy upon platelet activation to determine HIV-associated cardiovascular risk, British-Pharmacology-Society Meeting (Pharmacology), WILEY, Pages:3047-3047, ISSN:0007-1188
et al., 2019, Abacavir sulphate and tenofovir disoproxil fumarate/alafenamide differentially regulate endothelial dysfunction, WILEY, Pages:24-24, ISSN:1464-2662